Literature DB >> 9106698

Glyceryl trinitrate is an effective treatment for anal fissure.

J N Lund1, J H Scholefield.   

Abstract

PURPOSE: It has been suggested that chronic anal fissure is ischemic in origin because of poor blood supply and spasm of the internal anal sphincter. Nitric oxide donors such as glyceryl trinitrate (GTN) cause a chemical sphincterotomy leading to healing of the fissure. This study addresses the hypothesis that topical GTN ointment may be an effective nonsurgical treatment for chronic anal fissure.
METHODS: Thirty-nine consecutive patients (23 women; median age, 34 (range, 16-54) years) with chronic anal fissure presenting to the surgical outpatient department were treated for four to six weeks with 0.2 percent GTN ointment applied twice daily to the anoderm. Maximum anal resting pressure was measured at steady state before and after application of the ointment at the first visit. Patients were assessed at two weekly intervals.
RESULTS: Previous surgery for fissure had been performed in seven patients. There were 30 posterior and 9 anterior fissures. Resting maximum anal resting pressure fell from 122.1 +/- 44 to 72.5 +/- 33.3 cm of water (mean +/- standard deviation) by 20 minutes after application of ointment (P < 0.0001; paired t-test). Healing was complete in 14 patients at four weeks and in 33 patients at six weeks. Fissures recurred in five patients after treatment had been stopped. Four recurrences were successfully treated by further GTN ointment and one by sphincterotomy.
CONCLUSIONS: This study shows that most anal fissures can be treated nonsurgically with topically applied 0.2 percent GTN ointment. Prospective, randomized controlled trials are now needed, because nonsurgical treatment of anal fissure avoids permanent division of part of the sphincter and the consequent disturbance of continence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106698     DOI: 10.1007/bf02258394

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

Review 1.  Treatment of fissure in ano- revisited.

Authors:  Pravid J Gupta
Journal:  Afr Health Sci       Date:  2004-04       Impact factor: 0.927

Review 2.  Current concepts in anal fissures.

Authors:  Abraham A Ayantunde; Samuel A Debrah
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

3.  Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure.

Authors:  S E Kenny; T Irvine; C P Driver; A T Nunn; P D Losty; M O Jones; R R Turnock; G L Lamont; D A Lloyd
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 4.  [Fistulas and fissures. Part II: fissures].

Authors:  W Heitland
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

5.  Pharmacological characterization of neurogenic responses of the sheep isolated internal anal sphincter.

Authors:  M K Mundey; M Jonas; T Worthley; J H Scholefield; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 6.  Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.

Authors:  John L Wallace; Angela Ianaro; Gilberto de Nucci
Journal:  Dig Dis Sci       Date:  2017-07-21       Impact factor: 3.199

7.  Quality of life in patients with chronic anal fissure after topical treatment with diltiazem.

Authors:  Akira Tsunoda; Yasuharu Kashiwagura; Ken-Ichi Hirose; Tadanori Sasaki; Nobuyasu Kano
Journal:  World J Gastrointest Surg       Date:  2012-11-27

Review 8.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

9.  Idiopathic hypertensive anal canal: a place of internal sphincterotomy.

Authors:  Mohamed Farid; Ayman El Nakeeb; Mohamed Youssef; Waleed Omar; Elyamani Fouda; Tamer Youssef; Waleed Thabet; Hisham Abd Elmoneum; Wael Khafagy
Journal:  J Gastrointest Surg       Date:  2009-06-11       Impact factor: 3.452

10.  Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection.

Authors:  George Han; Luis R Martinez; Mircea Radu Mihu; Adam J Friedman; Joel M Friedman; Joshua D Nosanchuk
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.